eighteen chronic myeloid leukemia patients with hematological ( four patients ) or only cytogenetic ( 14 patients ) relapse occurring after t cell-depleted allogeneic bone marrow transplantation ( bmt ) have been treated with alpha 2b interferon ( ifn ) at a starting dose of 5 x 10 ( 6 ) i.u./m2 subcutaneously three times a week .
C0023473
chronic myeloid leukemia
C0021735
alpha 2b